Nuclear Medicine Equipment Market 2025 – Market Size & Segments Analysis, Industry Trends, Manufacturers Analysis, Opportunities and Forecast 2035

Page: 215 | Report Code: LS250722 | Research Suite: Report (PDF) & Market Data (Excel)

NOTE: Due to exhaustive nature of content, full ToC can't be uploaded. Please request Sample Pages to receive full table of content. 

Nuclear medicine equipment involves a range of specialized tools that use radioactive elements for the assessment of bodily functions and the identification of abnormalities at a molecular level. These instruments, designed to ensure patient safety and diagnostic precision, are necessary for a number of procedures, including imaging and therapy.

MARKET OVERVIEW

The nuclear medicine equipment market is valued at approximately USD 6.33 billion in 2024 and is projected to reach USD 10.4 billion by 2035 exhibiting a compound annual growth rate (CAGR) of 4.62% during the forecast period of 2025-2035. They are essential for diagnosing, managing, treating, and prevention of serious diseases, making them a crucial part of modern healthcare.


GROWTH DRIVERS

The rising prevalence of chronic diseases like cancer, cardiovascular diseases, and neurological disorders is significantly influencing the adoption of nuclear medicine equipment. For instance, according to the World Health Organization (WHO), there is going to be over 35 million new cancer cases in 2050, representing a 77% increase from the estimated 20 million cases in 2022. The demand for nuclear medicine equipment is fueled by the increase in the incidence of these diseases, requiring effective diagnostic and therapeutic solutions. As the global population ages, the prevalence of these ailments increases, resulting in a greater demand for nuclear medicine's diagnostic and therapeutic techniques as the use of nuclear medicine is crucial in identifying and treating these conditions.

The market growth is significantly driven by the increasing emphasis on personalized medicine and early disease detection. The U.S. Food and Drug Administration states that precision medicine, also known as personalized medicine, is a cutting-edge strategy for tailoring the prevention and treatment of disease. Unlike other imaging technologies, nuclear medicine offers distinct insights at the molecular and cellular levels. This facilitates the development of more tailored treatment approaches and enhanced disease targeting.

MARKET SEGMENTATION:

By Type -

·         Single Photon-Emission Computed Tomography (SPECT)

o   Standalone SPECT Systems

o   Hybrid SPECT Systems

·         Positron Emission Tomography (PET)

o   Standalone

o   Hybrid

·         Planar Scintigraphy

·         Other Equipment

By Application –

·         Cardiology

·         Oncology

·         Neurology

·         Endocrinology 

·         Nephrology/Urology

·         Orthopedics/Rheumatology

·         Theranostics 

·         Other Applications

By End User –

·         Hospitals

·         Imaging Centers

·         Ambulatory Surgical Centres (ASCs)

·         Academic and Research Centers

·         Other End Users

By Region -

·         North America

·         Europe

·         Asia Pacific

·         Latin America

·         Middle East & Africa

Nuclear Medicine Equipment Market By Type Segment Review:

In 2025, SPECT' segment is anticipated to hold the largest share of the market due to their critical role for various diagnostic procedures, including cardiac imaging, bone scans, and brain imaging. It enables the observation of blood flow, organ function, and other physiological processes.


Nuclear Medicine Equipment Market By Application Segment Review:

Cardiovascular diseases are the most common cause of death worldwide, which require effective diagnostic tools for early identification and treatment. Nuclear medicine techniques provide detailed information on blood flow to the heart muscles, making them very useful in the assessment of coronary heart disease. The need for nuclear medicine equipment in cardiology is further boosted by the aging of the world's population and unhealthy lifestyles, which also contribute to the rise in CVD cases.

Nuclear Medicine Equipment Market By End User Segment Review:

In 2025, hospitals’ segment is anticipated to hold the largest share of the market due to their comprehensive diagnostic and treatment capabilities. These facilities frequently possess a diverse selection of nuclear medicine equipment, including SPECT, PET, and hybrid imaging systems.

Nuclear Medicine Equipment Market By Region Segment Review:

The nuclear medicine equipment market exhibits significant regional variations, with North America leading the market in 2024 due to its advanced healthcare infrastructure, high adoption of cutting-edge imaging technologies, and a strong presence of leading manufacturers.

Nuclear Medicine Equipment Market Regional Synopsis:

The market in North America is growing due to the increasing prevalence of chronic diseases, technological advancements, favorable reimbursement policies and healthcare infrastructure, government initiatives and funding, and increasing adoption of hybrid imaging modalities.

Europe is another crucial market, driven by the increasing prevalence and strong awareness of chronic disorders such as cancers.

The market in Asia Pacific is expected to expand rapidly due to their rapid advancements in healthcare infrastructure, increasing awareness of early diagnosis, and growing surgical volumes.

In Latin America, the market is poised for steady growth, driven by the increasing prevalence of chronic diseases, government support and healthcare investments, rising demand for early and precise diagnostics, expansion of nuclear medicine facilities, and favorable reimbursement scenario.

The Middle East and Africa region is witnessing growth in the nuclear medicine equipment market due to the increasing prevalence of chronic diseases, rising healthcare expenditure, technological advancements, government initiatives, and growing awareness of the benefits of nuclear medicine.


Nuclear Medicine Equipment Market Key Challenges:

The stringent regional regulatory approval processes for both imaging systems and radiopharmaceuticals are one of the main factors hindering the growth of this market. Manufacturers are required to follow strict safety, performance, and radiation guidelines established by organizations like the FDA and EMA, which frequently results in long-lasting approval processes and expensive compliance procedures. In emerging economies, the absence of a sophisticated or stable regulatory environment makes it harder to swiftly introduce advanced nuclear imaging technologies.

Nuclear Medicine Equipment Market Competitive Landscape:

The global dry-nuclear medicine equipment market is characterized by a several established pharmaceutical companies and emerging players, each striving to enhance their market presence through various strategies such as product innovation and development, strategic partnerships and collaborations, mergers and acquisitions, geographic expansion, and focusing on customer-centric strategies.

In the nuclear medicine equipment market, companies are increasingly prioritizing product development and innovation. Businesses make significant investments in research and development to introduce advanced and innovative products. This includes the development of hybrid imaging technologies that provide improved diagnostic accuracy, like PET/CT and SPECT/CT. Additionally, they also emphasize the creation of new radiopharmaceuticals and integrating AI and machine learning into imaging processes.

Nuclear Medicine Equipment Market Key Players:

·         GE HealthCare

·         Siemens Healthineers

·         Koninklijke Philips

·         Canon Medical Systems Corporation

·         Mediso Ltd.

·         Lantheus Holdings

·         Cardinal Health

·         Biodex Medical Systems

·         Other Key & Niche Players

Buy Report

  • $1990
  • $2990